May 13 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 46.09 34.57 50.50 24.61
(+33.3 pct) (-3.6 pct) (+9.6 pct) (+41.5 pct)
Operating 13.95 6.27 14.00 7.14
(+122.4 pct) (+14.8 pct) (+0.3 pct) (+91.1 pct)
Recurring 14.16 6.35 14.20 7.22
(+123.1 pct) (+12.1 pct) (+0.3 pct) (+89.0 pct)
Net
Net 9.55 3.82 9.80 4.89
(+149.9 pct) (+4.4 pct) (+2.6 pct) (+115.0 pct)
EPS 79.29 yen 31.72 yen 81.38 yen 40.61 yen
Ann Div 16.00 yen 8.00 yen 16.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 16.00 yen 8.00 yen 16.00 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T